President Donald Trump unwrapped a massive drug pricing policy as CMS prepares for the next round of Medicare drug price negotiations; Vinay Prasad to take the helm at the FDA’s Center for Biologics ...

Inspired by the world's great Lego Masters, Arovella is taking a brick-by-brick approach to building its unique cancer ...

Dayers, nine T20s and a lone Test match to his credit, Vinay hasn't donned the Indian colours in three years. Even as ...

Bhopal/Jabalpur: Issuing notices to the National Medical Commission (NMC) and the Madhya Pradesh Medical Science University, ...

Bihar Chief Minister Nitish Kumar on Tuesday handed over a cheque of Rs 50 lakh as financial assistance to the family of BSF ...

Leading trade organizations representing the makers of cell and gene therapies are calling for a 10-year moratorium on ...

GSK plans to purchase an experimental drug for the liver disease MASH from Boston Pharmaceuticals for $1.2 billion upfront.

The drive revolves around a "10-for-one" policy laid out in a Trump executive order at the end of January, which demanded ...

Nearly 600 attendees learned about life sciences industry trends and heard from 93 presenting biotechnology companies at ...

Ablynx is looking for new partners to take its rheumatoid arthritis drug vobarilizumab into phase 3 development, after AbbVie turned down an option to license the drug. AbbVie has already paid the ...

A multibillion-dollar partnership between AbbVie and Genmab risks being soured by a lawsuit claiming misappropriation of trade secrets. Specifically, it focuses on the use of disaccharides to ...

It seems Eisai and Biogen have another hurdle to jump over in their bid to get EU approval for their Alzheimer's disease therapy Leqembi. In the latest development, the European Commission has ...